Tech Center 1600 • Art Units: 1654
This examiner grants 100% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18260190 | CO-FORMULATION OF POLYMYXINS FOR INHALATION | Non-Final OA | Purdue Research Foundation |
| 18546477 | TIRZEPATIDE THERAPEUTIC METHODS | Non-Final OA | Eli Lilly and Company |
| 18279772 | NLRP3 INFLAMMASOME INHIBITORY PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASES | Non-Final OA | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18556772 | PEPTIDES INHIBITING COVID-19 | Non-Final OA | QUANTBIORES A/S |
| 18550807 | PROTEINS AND USES THEREOF | Non-Final OA | Macrobiome Therapeutics Pty Ltd |
| 18320895 | METHOD FOR REPAIRING SERTOLI CELL INJURY IN TESTES | Non-Final OA | The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University |
| 18317002 | NOVEL FORMULATIONS FOR ORAL ADMINISTRATION OF THERAPEUTIC AGENTS TO THE GASTROINTESTINAL TRACT | Non-Final OA | Hôpital Lyon Sud, HOSPICES CIVILS DE LYON |
| 18309154 | COMPOSITIONS COMPRISING AAV-BINDING POLYPEPTIDES AND METHODS OF USING THE SAME | Non-Final OA | Isolere Bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy